The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India. - Babu G; Saldanha SC; Kuntegowdanahalli Chinnagiriyappa L; Jacob LA; Mallekavu SB; Dasappa L; Kiran PR; Sreevatsa A; Appachu S; Unnikrishnan V; Arroju V (Chemotherapy research and practice, 2016)